EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
Launched by RIGSHOSPITALET, DENMARK · Feb 29, 2016
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Abstract: There are currently over 1½ million people across Europe infected with HIV. The epidemic continues to intensify in the Eastern European region where prevalence of HIV will continue to increase in the years to come. There are significant problems with the management of this public health crisis. Available antiretroviral therapy (ART) - although extremely effective - does not eradicate HIV and hence has to be continued for life. Other limitations are the development of resistance, adverse effects of treatment, and the requirement for strict adherence. Despite these limitations, the ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • HIV-1 infected patients regardless of CD4 cell count and ART status
- • Must be positive for antibodies against HCV regardless of HCV-RNA status, fibrosis stage and prior HCV therapy
- Exclusion Criteria:
- • Patients under 16 years of age
- • Already enrolled in EuroSIDA through earlier cohort
- • Predefined number of patients has been reached
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
London, , United Kingdom
Madrid, , Spain
Copenhagen, , Denmark
Zürich, , Switzerland
Edinburgh, , United Kingdom
Lyon, , France
Barcelona, , Spain
Odense, , Denmark
Madrid, , Spain
Badalona, Barcelona, Spain
Stockholm, , Sweden
Stockholm, , Sweden
Lausanne, , Switzerland
Milano, , Italy
Haifa, , Israel
Basel, , Switzerland
Badalona, , Spain
Athens, , Greece
Jerusalem, , Israel
Milano, , Italy
Vienna, , Austria
Brighton, , United Kingdom
London, , United Kingdom
Oslo, , Norway
Antwerp, , Belgium
Hamburg, , Germany
Luxembourg, , Luxembourg
Bialystok, , Poland
Wroclaw, , Poland
Lisbon, , Portugal
Lisbon, , Portugal
Modena, , Italy
Dublin, , Ireland
Poznan, , Poland
Reykjavik, , Iceland
Roskilde, , Denmark
Valencia, , Spain
London, , United Kingdom
Malmö, , Sweden
St.Gallen, , Switzerland
Lisbon, , Portugal
Bonn, , Germany
Bern, , Switzerland
Paris, , France
Vilnius, , Lithuania
Gdansk, , Poland
Buenos Aires, , Argentina
Innsbruck, , Austria
Gomel, , Belarus
Gomel, , Belarus
Minsk, , Belarus
Brussels, , Belgium
Gent, , Belgium
Sarajevo, , Bosnia And Herzegovina
Zagreb, , Croatia
Plzeň, , Czechia
Prague, , Czechia
Hillerød, , Denmark
Hvidovre, , Denmark
Skejby, , Denmark
Kohtla Järve, , Estonia
Tallinn, , Estonia
Bordeaux, , France
Lyon, , France
Nice, , France
Paris, , France
Paris, , France
Paris, , France
Tbilisi, , Georgia
Cologne, , Germany
Eppendorf, , Germany
Frankfurt Am Main, , Germany
Hamburg, , Germany
Hannover, , Germany
München, , Germany
Athens, , Greece
Athens, , Greece
Budapest, , Hungary
Rehovot, , Israel
Tel Aviv, , Israel
Bergamo, , Italy
Milano, , Italy
Napoli, , Italy
Rome, , Italy
Rome, , Italy
Riga, , Latvia
Vilnius, , Lithuania
Amsterdam, , Netherlands
Chorzow, , Poland
Lodz, , Poland
Szczecin, , Poland
Warszawa, , Poland
Bucuresti, , Romania
Kaliningrad, , Russian Federation
Nizhny Novgorod, , Russian Federation
St Petersburg, , Russian Federation
Veliky Novgorod, , Russian Federation
Belgrade, , Serbia
Bratislava, , Slovakia
Ljubljana, , Slovenia
Barcelona, , Spain
Madrid, , Spain
Vitoria Gasteiz, , Spain
Genève, , Switzerland
Kharkiv, , Ukraine
Luhansk, , Ukraine
Lviv, , Ukraine
Odessa, , Ukraine
Simferopol, , Ukraine
London, , United Kingdom
Patients applied
Trial Officials
Gilles Wandeler, Dr. med.
Study Chair
University of Bern, Switzerland.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials